Human papillomavirus (HPV) is required but not sufficient for cervical carcinoma (CxCa) development. Oestradiol (E 2 ) promotes CxCa development in K14E7 transgenic mice expressing the HPV16 E7 oncoprotein under the control of the keratin (K14) promoter. E 2 mainly functions through oestrogen receptor  (ER). However, the role of ER in human CxCa has been underappreciated largely because it is not expressed in carcinoma cells. We have shown that deletion of Esr1 (the ER-coding gene) in the cervical stroma of K14E7 mice promotes regression of cervical intraepithelial neoplasia (CIN), the precursor lesion of CxCa. Here, we deleted Esr1 in the cervical epithelium but not in the stroma. We found that E 2 induced cervical epithelial cell proliferation in epithelial ER-deficient mice. We also found that E 2 promoted the development of CIN and CxCa in epithelial ER-deficient K14E7 mice and that all neoplastic epithelial cells were negative for ER. In addition, proliferation indices were similar between ER -and ER + CxCa. These results indicate that epithelial ER is not necessary for E 2 -induced CIN and CxCa. Taking these findings together, we conclude that stromal ER rather than epithelial ER mediates oncogenic E 2 signalling in CxCa. Our results support stromal ER signalling as a therapeutic target for the disease.
Introduction
Cervical carcinoma (CxCa) caused by high-risk human papillomavirus (HPV) is the fourth leading cause of cancer death in women worldwide [1] . Among more than a dozen high-risk HPVs, HPV16 is responsible for 50% of CxCa cases. The HPV E6 and E7 oncoproteins are best known for their ability to inactivate p53 and pRb, respectively. Expression of E6 and E7 is not sufficient to cause CxCa in mice or to transform human cervical keratinocytes in vitro [2, 3] .
Long-term use of oral contraceptives and high parity are associated with an increased risk of CxCa in HPV-infected women [4, 5] . Exposure to diethylstilboestrol (synthetic oestrogen) increases the risk of cervical intraepithelial neoplasia (CIN), the precursor lesion for CxCa [6] . Breast cancer patients who have used aromatase inhibitors are at reduced risk of CIN development as compared with non-users [7] . Aromatase is required for the biosynthesis of oestradiol (E 2 ), the most potent oestrogen. Although these observations are in support of oestrogen being a risk factor, its mechanism in the pathogenesis of CxCa has been underexplored. In a transgenic mouse model expressing HPV16 E7 (K14E7), E 2 promotes the development of CxCa preceded by CIN1, CIN2, and CIN3, which recapitulates human multistage cervical carcinogenesis [3] . Germline knockout of the murine oestrogen receptor α (ERα)-coding gene (Esr1) abrogates cervical carcinogenesis in K14E7 mice, demonstrating the requirement for ERα, a ligand-dependent transcription factor [8] . However, its mechanism in human CxCa has been underappreciated. ERα is expressed in cancer-associated stroma, but not in cancer epithelial cells, suggesting that ERα in the stroma, rather than tumour cells, promotes CxCa [9] . In the present study, we show that specific deletion of epithelial Esr1 does not abrogate the development of CIN and CxCa. Our results support the notion that epithelial ERα plays little role in the cooperation of HPV with E 2 in promoting CxCa.
Materials and methods
Mouse strains are described in supplementary material, Table S1 . Hormone treatment and procedures are described in supplementary material, Supplementary materials and methods. All procedures for mice were supplementary material, Supplementary materials and methods. Antibodies and immunohistochemistry (IHC) conditions are described in supplementary material, Table S2 . One-sided Fisher's exact tests were used for disease incidence, and one-sided Wilcoxon rank sum tests were used for epithelium thickness, cell proliferation, apoptosis, and disease severity.
Results and discussion
The cervical epithelium of Esr1 ed/ed mice shows partial responses to E 2
To study the role of epithelial ERα in the cervix, we employed Wnt7a-Cre/Esr1 f /f mice (referred to as Esr1 ed/ed mice hereafter). ERα was specifically ablated in the cervical epithelia of Esr1 ed/ed mice, as confirmed by the absence of epithelial progesterone receptor (PR) ( Figure 1A ), a marker of ERα function [10] . E 2 increased cervical epithelium thickness in Esr1 f /f mice (p = 0.02) and Esr1 ed/ed mice (p = 0.03) ( Figure 1B Figure 1C ). Expression of keratin 10 (K10) was increased in E 2 -treated Esr1 f /f mice, but not in Esr1 ed/ed mice ( Figure 1D ), indicating the requirement for epithelial ERα for differentiation of the cervical squamous epithelium. E 2 increased neither epithelial thickness nor proliferation in the Esr1 −/− cervix (supplementary material, Figure S1A ,B). These results indicate that, although epithelial ERα is necessary for full E 2 responses, stromal ERα also mediates E 2 -induced proliferation of cervical epithelial cells, consistent with previous findings that stromal ERα is necessary and sufficient for E 2 -induced epithelial cell proliferation in the uterus and vagina [11] .
ed/ed mice Oestrogen-dependent oestrogen receptor-negative cervical cancer 149 Figure 2B ), confirming absence of expression of ERα. These results rule out the possibility that some epithelial cells escaped Esr1 deletion and became neoplastic. We concluded that epithelial ERα is not required for the development of CIN and CxCa. This is the first time that the ERα status of human CxCa, in which cancer cells are ERα − and the stroma is ERα + , has been mimicked [9] . Expression of oestrogen receptor β (ERβ), the other nuclear oestrogen receptor (encoded by Esr2), was undetectable in CIN and CxCa in K14E7/Esr1 ed/ed mice, suggesting that there was no compensatory overexpression of ERβ. ERβ was detected in the ovaries of Esr2 +/+ mice but not in those of Esr2 −/− mice, verifying specificity of the antibody (supplementary material, Figure S2A,B) . We have demonstrated that deletion of stromal Esr1 promotes CIN regression in K14E7 mice [12] . Taking these findings together, we conclude that stromal ERα is the major player in CIN and CxCa. FGF7, FGF9, HBEGF, IGF1, IL1A, CXCL1 and CXCL5 are upregulated by ERα in the cervical stroma [12] [13] [14] . It is plausible that secretory factors encoded by these stromal ERα target genes activate oncogenic signalling pathways in the epithelium through their cognate receptors on the plasma membranes of epithelial cells.
ERα
+ and ERα -CxCa show similar differentiation status, biomarker expression, and growth
CIN and CxCa arising in K14E7/Esr1
ed/ed and K14E7/Esr1 f /f mice showed similar histology ( Figure 2C ). It was notable that non-diseased epithelium in K14E7/Esr1 ed/ed mice was as hypoplastic as the entire epithelium of NTG/Esr1 ed/ed mice ( Figure 2C , inset). Expression of K10 in CIN and CxCa was similar between K14E7/Esr1 ed/ed and K14E7/Esr1 f /f mice ( Figure 2D ). Differentiation of cervical epithelial cells depends on epithelial ERα ( Figure 1D ). These results indicate that neoplastic cells in K14E7/Esr1 ed/ed mice acquired an ERα-independent differentiation programme. Expression of p16 and Mcm7, which are biomarkers of E7 function [15] , was similarly upregulated in CIN and CxCa in K14E7/Esr1 ed/ed and K14E7/Esr1 f /f mice as compared with NTG control mice ( Figure 3A,B) . The rarity of Mcm7 + and Ki67 + basal cells in NTG/Esr1 ed/ed mice suggests that most epithelial cells are quiescent, and that epithelial ERα is required for proliferation of normal epithelial cells in response to long-term E 2 treatment ( Figure 3B ; supplementary material, Figure S3 ). Proliferation of cancer cells was similar between K14E7/Esr1 f /f and K14E7/Esr1 ed/ed mice ( Figure 3C ). Apoptotic indices of carcinomas were also similar between the two genotypes ( Figure 3D ), indicating that ERα in cancer epithelial cells is not required for proliferation and survival of CxCa cells.
Epithelial ERα may play a role in an early stage of cervical carcinogenesis 2A) and human cervix [9] . The entire epithelium was hypoplastic in NTG/Esr1 ed/ed mice, but hyperplastic in NTG/Esr1 f /f mice ( Figure 2C ). This difference in baseline state of the epithelium may have contributed to the reduced cancer burden. An improved system allowing temporal deletion of epithelial Esr1 is required for better recapitulation of epithelial ERα status in human. Although most non-diseased cervical epithelia in K14E7/Esr1 ed/ed mice were hypoplastic and undifferentiated ( Figure 2C,D) , CIN and CxCa in these mice were as differentiated and proliferative as those in K14E7/Esr1 f /f mice ( Figures 2D and 3C ). These results suggest that some ERα − epithelial cells acquired molecular changes mimicking the ERα pathway, and were selected during carcinogenesis. It appeared that E7 provided a selection advantage, because a hyperplastic epithelium was absent in NTG/Esr1 ed/ed mice ( Figure 2C ). It appeared that selection was a long-term process, because there was no hyperplastic epithelium in K14E7/Esr1 ed/ed mice treated with E 2 for 2 months (data not shown). Gene expression profiling of CxCa suggests overactivation of ERα even if tumour cells do not express the receptor [16] , suggesting transcriptional activation of ERα target genes through an ERα-independent mechanism. This transcriptome change may be due to genetic and/or epigenetic alterations caused by E7. HPV16 E7 inhibits DNA damage repair and induces genomic instability [17] . It also causes epigenetic reprogramming by inducing expression of KDM6A and KDM6B histone demethylases [18] . Taking these findings together, we argue that epithelial ERα plays a positive role, if any, in the development of CIN1, but not in its progression to higher-grade disease.
Our results demonstrate that mouse cervical neoplastic diseases occur in the absence of epithelial ERα, recapitulating the human disease. The data described herein and published observations support the idea that oncogenic E 2 signalling is mediated mainly by stromal ERα in the cervix [12, 13] . Further studies are warranted to determine the molecular mechanisms of stromal ERα and signalling pathways complementing the loss of epithelial ERα in CxCa. 
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